DisruPep
Biotechnology & Lifesciences Awards - 2025
Leading Innovators in Amyloid-Targeting Solutions 2025
Disrupep is a biotech company developing first-in-class peptide-based therapies targeting unmet medical needs in neurology and metabolic diseases. Its lead candidate aims to prevent and reverse Type 2 Diabetes, with additional programs for ALS, Parkinson’s, PTSD, and suicide prevention.